Back

Clinical impact of combined LDL cholesterol and remnant cholesterol phenotypes after coronary revascularization: insights from a nationwide cohort

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Lipid profiling and coronary artery disease (2) Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Jung-Hee Lee

Wonju Severance Christian Hospital, Wonju (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Proteomic changes associated with vupanorsen therapy in TRANSLATE-TIMI-70
Doctor R. Bansal (Hamilton, CA)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) levels in children with genetically confirmed heterozygous familial hypercholesterolaemia
Miss K. Martins Barreto Borges (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Association between remnant cholesterol at the age of 30 and all-cause mortality during long-term follow-up: a cohort study
Doctor E. Aaseth (Oslo, NO)
Abstract Slides
Presentation thumbnail
Small dense LDL, clinical characteristics and survival - an analysis of LIPIDOGRAM2004-2015 cohort studies
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Real-world prediagnosis lipid management in parents identified through child-initiated reverse cascade screening for familial hypercholesterolaemia
Doctor R. Tani (Kagawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Lipid profiling and coronary artery disease (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol and its role in patients with coronary atherosclerosis evaluated by coronary CT
13 December 2025
thumbnail
Congress Presentation
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
4 April 2025
thumbnail
Congress Presentation
Determinants of revascularization and outcomes in patients with suspected/known CAD
20 May 2024
thumbnail
Congress Presentation
High levels of small dense LDL cholesterol potentiate the risk of poor glycemic management for long-term prognosis in patients with stable coronary artery disease
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources